Access cutting-edge pancreatic cancer treatment through this clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.
Access pancreatic cancer specialists in Houston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pancreatic cancer treatment provided free
Abbreviated Title: Neoadjuvant FOLFIRINOX combined with Pembrolizumab followed by surgery for patients with resectable pancreatic cancer Trial Phase: Phase II Clinical Indication: Pancreatic ductal adenocarcinoma; Adenocarcinoma; AJCC I, II, or III; 1st Line neoadjuvant Trial Type: Interventional prospective Type of control: Historical Route of administration: IV Treatment Groups: Neoadjuvant FOLFIRINOX combined with Pembrolizumab followed by surgery for patients with resectable pancreatic cance
Sponsor: Baylor College of Medicine
Check if you qualify for this pancreatic cancer clinical trial in Houston, TX
If you're searching for pancreatic cancer treatment options in Houston, TX, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pancreatic cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.